US Stock MarketDetailed Quotes

CLNN Clene

Watchlist
  • 4.2700
  • +0.0400+0.95%
Close Feb 25 16:00 ET
  • 4.2000
  • -0.0700-1.64%
Post 20:01 ET
35.55MMarket Cap-0.81P/E (TTM)

About Clene Company

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Company Profile

SymbolCLNN
Company NameClene
Listing DateAug 27, 2018
Founded2013
CEOMr. Robert Etherington
MarketNASDAQ
Employees85
Fiscal Year Ends12-31
Address6550 South Millrock Drive,Suite G50
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84121
Phone1-801-676-9695

Company Executives

  • Name
  • Position
  • Salary
  • Robert Etherington
  • President, Chief Executive Officer and Director
  • 1.71M
  • Mark Mortenson
  • Chief Science Officer
  • 1.38M
  • Morgan R. Brown
  • Chief Financial Officer and Principal Accounting Officer
  • 993.70K
  • David J. Matlin
  • Chairman of the Board
  • --
  • Dr. Arjun JJ Desai, M.D.
  • Independent Director
  • --
  • Professor Matthew Kiernan, PhD
  • Independent Director
  • --
  • Shalom Jacobovitz
  • Independent Director
  • --
  • Reed Neil Wilcox
  • Independent Director
  • --
  • Jonathon T. Gay
  • Independent Director
  • --
  • Dr. Vallerie V. McLaughlin, M.D.
  • Independent Director
  • --
  • Alison H. Mosca
  • Independent Director
  • --

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More